{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T19:59:10Z","timestamp":1723060750868},"reference-count":28,"publisher":"American Society for Microbiology","issue":"4","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Clin Vaccine Immunol"],"published-print":{"date-parts":[[2008,4]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>Currently, there is no routine monitoring of an immune response to the anthrax vaccine. Simple on-site tests are needed to evaluate the antibody response of anthrax-vaccinated individuals in the Armed Forces and others at high risk. Using a prototype lateral flow assay (LFA) (R. E. Biagini, D. L. Sammons, J. P. Smith, B. A. MacKenzie, C. A. F. Striley, J. E. Snawder, S. A. Robertson, and C. P. Quinn, Clin. Vaccine Immunol. 13:541-546, 2006), we investigated the agreement between a validated anthrax protective antigen (PA) immunoglobulin G (IgG) enzyme-linked immunosorbent assay (ELISA) and the LFA for 335 unvaccinated and vaccinated subjects. We also investigated the performance of the LFA under the following conditions: thermal shock (i.e., thermal cycling between temperature extremes), high temperature\/high relative humidity, high temperature\/low relative humidity, and low temperature\/low relative humidity. With the anti-PA ELISA used as a standard, the LFA was shown to be optimally diagnostic at 11 \u03bcg\/ml anti-PA-specific IgG. At this concentration, the LFA specificity and sensitivity were 98% (95% confidence interval [CI], 97% to 100%) and 92% (CI, 88% to 97%), respectively. Receiver operating characteristic curve analysis yielded an area under the curve value of 0.988 (CI, 0.976 to 1.00), suggesting that the LFA is an extremely accurate diagnostic test. For \u22644 or \u226550 \u03bcg\/ml PA-specific IgG, the LFA results for each environmental condition were identical to those obtained in the laboratory. These data indicate that this rapid point-of-care test would be a feasible tool in monitoring the serological antibody responses of individuals that have been vaccinated against anthrax.<\/jats:p>","DOI":"10.1128\/cvi.00473-07","type":"journal-article","created":{"date-parts":[[2008,3,6]],"date-time":"2008-03-06T02:10:32Z","timestamp":1204769432000},"page":"644-649","update-policy":"http:\/\/dx.doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":4,"title":["Rapid Point-of-Care Test To Detect Broad Ranges of Protective Antigen-Specific Immunoglobulin G Concentrations in Recipients of the U.S.-Licensed Anthrax Vaccine"],"prefix":"10.1128","volume":"15","author":[{"given":"Diane R.","family":"Bienek","sequence":"first","affiliation":[{"name":"Naval Institute for Dental and Biomedical Research, Great Lakes, Illinois"},{"name":"General Dynamics Information Technology, Frederick, Maryland"},{"name":"Biological Monitoring Laboratory Section, Biomonitoring and Health Assessment Branch, National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control and Prevention, Cincinnati, Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond E.","family":"Biagini","sequence":"additional","affiliation":[{"name":"Naval Institute for Dental and Biomedical Research, Great Lakes, Illinois"},{"name":"General Dynamics Information Technology, Frederick, Maryland"},{"name":"Biological Monitoring Laboratory Section, Biomonitoring and Health Assessment Branch, National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control and Prevention, Cincinnati, Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David G.","family":"Charlton","sequence":"additional","affiliation":[{"name":"Naval Institute for Dental and Biomedical Research, Great Lakes, Illinois"},{"name":"General Dynamics Information Technology, Frederick, Maryland"},{"name":"Biological Monitoring Laboratory Section, Biomonitoring and Health Assessment Branch, National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control and Prevention, Cincinnati, Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerome P.","family":"Smith","sequence":"additional","affiliation":[{"name":"Naval Institute for Dental and Biomedical Research, Great Lakes, Illinois"},{"name":"General Dynamics Information Technology, Frederick, Maryland"},{"name":"Biological Monitoring Laboratory Section, Biomonitoring and Health Assessment Branch, National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control and Prevention, Cincinnati, Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah L.","family":"Sammons","sequence":"additional","affiliation":[{"name":"Naval Institute for Dental and Biomedical Research, Great Lakes, Illinois"},{"name":"General Dynamics Information Technology, Frederick, Maryland"},{"name":"Biological Monitoring Laboratory Section, Biomonitoring and Health Assessment Branch, National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control and Prevention, Cincinnati, Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shirley A.","family":"Robertson","sequence":"additional","affiliation":[{"name":"Naval Institute for Dental and Biomedical Research, Great Lakes, Illinois"},{"name":"General Dynamics Information Technology, Frederick, Maryland"},{"name":"Biological Monitoring Laboratory Section, Biomonitoring and Health Assessment Branch, National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control and Prevention, Cincinnati, Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1046\/j.1365-2672.1999.00899.x","volume":"87","year":"1999","unstructured":"Baillie, L. W. J., K. Fowler, and P. C. B. Turnbull. 1999. Human immune responses to the UK human anthrax vaccine. J. Appl. Microbiol.87:306-308.","journal-title":"J. Appl. Microbiol."},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/CDLI.8.6.1145-1149.2001"},{"key":"e_1_3_2_4_2","first-page":"50","volume":"11","year":"2004","unstructured":"Biagini, R. E., D. L. Sammons, J. P. Smith, B. A. MacKenzie, C. A. F. Striley, V. Semenova, E. Steward-Clark, K. Stamey, A. E. Freeman, C. P. Quinn, and J. E. Snawder. 2004. Comparison of a multiplexed fluorescent covalent microsphere immunoassay and an enzyme-linked immunosorbent assay for measurement of human immunoglobulin G antibodies to anthrax toxins. Clin. Diagn. Lab. Immunol.11:50-55.","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.13.5.541-546.2006"},{"key":"e_1_3_2_6_2","doi-asserted-by":"crossref","first-page":"5978","DOI":"10.1016\/j.vaccine.2007.05.043","volume":"25","year":"2007","unstructured":"Bienek, D. R., C. K. Chang, and M. E. Cohen. 2007. Detection of anti-protective antigen salivary IgG antibodies in recipients of the US licensed vaccine. Vaccine25:5978-5984.","journal-title":"Vaccine"},{"key":"e_1_3_2_7_2","unstructured":"Reference deleted."},{"key":"e_1_3_2_8_2","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0140-6736(03)12270-2","volume":"361","year":"2003","unstructured":"Chanteau, S., L. Rahalison, L. Ralafiarisoa, J. Foulon, M. Ratsitorahina, L. Ratsifasoamanana, E. Carniel, and F. Nato. 2003. Development and testing of a rapid diagnostic test for bubonic and pneumonic plague. Lancet361:211-216.","journal-title":"Lancet"},{"key":"e_1_3_2_9_2","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.trstmh.2006.09.007","volume":"101","year":"2007","unstructured":"Chiodini, P. L., K. Bowers, P. Jorgensen, J. W. Barnwell, K. K. Grady, J. Luchavez, A. H. Moody, A. Cenizal, and D. Bell. 2007. The heat stability of Plasmodium lactate dehydrogenase-based and histidine-rich protein 2-based malaria rapid diagnostic tests. Trans. R. Soc. Trop. Med. Hyg.101:331-337.","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1016\/S0264-410X(01)00021-4","volume":"19","year":"2001","unstructured":"Fellows, P. F., M. K. Linscott, B. E. Ivins, M. L. M. Pitt, C. A. Rossi, P. H. Gibbs, and A. M. Friedlander. 2001. Efficacy of a human anthrax vaccine in guinea pigs, rabbits, and rhesus macaques against challenge by Bacillus anthracis isolates of diverse geographical origin. Vaccine19:3241-3247.","journal-title":"Vaccine"},{"key":"e_1_3_2_11_2","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1080\/1047322X.1990.10389587","volume":"5","year":"1990","unstructured":"Hornung, R., and L. Reed. 1990. Estimate of average concentration in the presence of non-detectable values. Appl. Occup. Environ. Hyg.5:46-51.","journal-title":"Appl. Occup. Environ. Hyg."},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/0264-410X(94)90027-2","volume":"12","year":"1994","unstructured":"Ivins, B. E., P. F. Fellows, and G. O. Nelson. 1994. Efficacy of a standard human anthrax vaccine against Bacillus anthracis spore challenge in guinea-pigs. Vaccine12:872-874.","journal-title":"Vaccine"},{"key":"e_1_3_2_13_2","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S0264-410X(98)80112-6","volume":"16","year":"1998","unstructured":"Ivins, B. E., M. L. M. Pitt, P. F. Fellows, J. W. Farchaus, G. E. Benner, D. M. Waag, S. F. Little, G. W. Anderson, P. H. Gibbs, and A. M. Friedlander. 1998. Comparative efficacy of experimental anthrax vaccine candidates against inhalation anthrax in rhesus macaques. Vaccine16:1141-1148.","journal-title":"Vaccine"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.60.2.662-668.1992"},{"key":"e_1_3_2_15_2","unstructured":"The anthrax vaccine. Is it safe? Does it work? 2002"},{"key":"e_1_3_2_16_2","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.vaccine.2006.11.005","volume":"25","year":"2007","unstructured":"Lininger, L. A., M. E. Cullum, M. B. Lyles, and D. R. Bienek. 2007. The impact of incomplete vaccination schedules on the magnitude and duration of protective antigen-specific IgG responses in recipients of the US licensed anthrax vaccine. Vaccine25:1619-1625.","journal-title":"Vaccine"},{"key":"e_1_3_2_17_2","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.vaccine.2003.07.004","volume":"22","year":"2004","unstructured":"Little, S. F., B. E. Ivins, P. F. Fellows, M. L. M. Pitt, S. L. W. Norris, and G. P. Andrews. 2004. Defining a serological correlate of protection in rabbits for a recombinant anthrax vaccine. Vaccine22:422-430.","journal-title":"Vaccine"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.52.2.509-512.1986"},{"key":"e_1_3_2_19_2","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.trstmh.2005.01.001","volume":"99","year":"2005","unstructured":"Lon, C. T., S. Alcantara, J. Luchavez, R. Tsuyuoka, and D. Bell. 2005. Positive control wells: a potential answer to remote-area quality assurance of malaria rapid diagnostic tests. Trans. R. Soc. Trop. Med. Hyg.99:493-498.","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"e_1_3_2_20_2","first-page":"1","volume":"2","year":"2007","unstructured":"Nato, F., A. Phalipon, L. P. T. Nguyen, T. T. Diep, P. Sansonetti, and Y. Germani. 2007. Dipstick for rapid diagnosis of Shigella flexneri 2a in stool. PLoS ONE2:1-7.","journal-title":"PLoS ONE"},{"key":"e_1_3_2_21_2","doi-asserted-by":"crossref","first-page":"4768","DOI":"10.1016\/S0264-410X(01)00234-1","volume":"19","year":"2001","unstructured":"Pitt, M. L., S. F. Little, B. E. Ivins, P. Fellows, J. Barth, J. Hewetson, P. Gibbs, M. Dertzbaugh, and A. M. Friedlander. 2001. In vitro correlate of immunity in a rabbit model of inhalational anthrax. Vaccine19:4768-4773.","journal-title":"Vaccine"},{"key":"e_1_3_2_22_2","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1046\/j.1365-2672.1999.00897.x","volume":"87","year":"1999","unstructured":"Pitt, M. L. M., S. Little, B. E. Ivins, P. Fellows, J. Boles, J. Barth, J. Hewetson, and A. M. Friedlander. 1999. In vitro correlate of immunity in an animal model of inhalational anthrax. J. Appl. Microbiol.87:304.","journal-title":"J. Appl. Microbiol."},{"key":"e_1_3_2_23_2","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1016\/S0264-410X(02)00058-0","volume":"20","year":"2002","unstructured":"Pittman, P. R., D. Hack, J. Mangiafico, P. Gibbs, K. T. McKee, A. M. Friedlander, and M. H. Sjogren. 2002. Antibody response to a delayed booster dose of anthrax vaccine and botulinum toxoid. Vaccine20:2107-2115.","journal-title":"Vaccine"},{"key":"e_1_3_2_24_2","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0264-410X(00)00174-2","volume":"19","year":"2000","unstructured":"Pittman, P. R., J. A. Mangiafico, C. A. Rossi, T. L. Cannon, P. H. Gibbs, G. W. Parker, and A. M. Friedlander. 2000. Anthrax vaccine: increasing intervals between the first two doses enhances antibody response in humans. Vaccine19:213-216.","journal-title":"Vaccine"},{"key":"e_1_3_2_25_2","doi-asserted-by":"crossref","first-page":"3654","DOI":"10.1016\/j.vaccine.2006.01.054","volume":"24","year":"2006","unstructured":"Pittman, P. R., S. L. Norris, J. G. Barrera Oro, D. Bedwell, T. L. Cannon, and K. T. McKee. 2006. Patterns of antibody response in humans to the anthrax vaccine adsorbed (AVA) primary (six-dose) series. Vaccine24:3654-3660.","journal-title":"Vaccine"},{"key":"e_1_3_2_26_2","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.3201\/eid0810.020380","volume":"8","year":"2002","unstructured":"Quinn, C. P., V. A. Semenova, C. M. Elie, S. Romero-Steiner, C. Greene, H. Li, K. Stamey, E. Steward-Clark, D. S. Schmidt, E. Mothershed, J. Pruckler, S. Schwartz, R. F. Benson, L. O. Helsel, P. F. Holder, S. E. Johnson, M. Kellum, T. Messmer, W. L. Thacker, L. Besser, B. D. Plikaytis, T. H. Taylor, A. E. Freeman, K. J. Wallace, P. Dull, J. Sejvar, E. Bruce, R. Moreno, A. Schuchat, J. R. Lingappa, N. Marano, S. K. Martin, J. Walls, M. Bronsdon, G. M. Carlone, M. Bajani-Ari, D. A. Ashford, D. S. Stephens, and B. A. Perkins. 2002. Specific, sensitive, and quantitative enzyme-linked immunosorbent assay for human immunoglobulin G antibodies to anthrax toxin protective antigen. Emerg. Infect. Dis.8:1103-1110.","journal-title":"Emerg. Infect. Dis."},{"key":"e_1_3_2_27_2","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.biologicals.2006.07.003","volume":"35","year":"2007","unstructured":"Selinsky, C. L., V. D. Whitlow, L. R. Smith, D. C. Kaslow, and H. M. Horton. 2007. Qualification and performance characteristics of a quantitative enzyme-linked immunosorbent assay for human IgG antibodies to anthrax lethal factor antigen. Biologicals35:123-129.","journal-title":"Biologicals"},{"key":"e_1_3_2_28_2","first-page":"919","volume":"11","year":"2004","unstructured":"Semenova, V. A., E. Steward-Clark, K. L. Stamey, T. H. Taylor, D. S. Schmidt, S. K. Martin, N. Marano, and C. P. Quinn. 2004. Mass value assignment of total and subclass immunoglobulin G in a human standard anthrax reference serum. Clin. Diagn. Lab. Immunol.11:919-923.","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.52.2.356-363.1986"}],"container-title":["Clinical and Vaccine Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00473-07","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00473-07","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T20:39:45Z","timestamp":1627591185000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CVI.00473-07"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["10.1128\/CVI.00473-07"],"URL":"https:\/\/doi.org\/10.1128\/cvi.00473-07","relation":{},"ISSN":["1556-6811","1556-679X"],"issn-type":[{"value":"1556-6811","type":"print"},{"value":"1556-679X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,4]]},"assertion":[{"value":"2007-11-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2008-02-20","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}